Bachem Holding AG (LON:0QND)

Market Cap	4.37B +14.0%
Revenue (ttm)	651.29M +14.8%
Net Income	139.42M +23.7%
EPS	1.86 +23.8%
Shares Out	n/a
PE Ratio	31.34
Forward PE	25.32
Dividend	0.78 (1.25%)
Ex-Dividend Date	May 5, 2025

Volume	7,662
Average Volume	31,521
Open	62.00
Previous Close	58.82
Day's Range	61.60 - 62.70
52-Week Range	43.98 - 76.00
Beta	0.98
RSI	51.73
Earnings Date	Mar 12, 2026

About Bachem Holding AG

Bachem Holding AG, together with its subsidiaries, provides products for research, clinical development, and commercial application to pharmaceutical and biotechnology companies worldwide. It engages in the development, production, and regulatory support of peptide active pharmaceutical ingredients, such as peptide and oligonucleotide new chemical entities (NCEs). The company also offers commercial NCEs and generics; and project management, quality and regulatory, analytical, good manufacturing practice production, research grade production, an...

• Industry: Medical - Pharmaceuticals
• Sector: Healthcare
• Founded: 1971
• Employees: 2,292
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0QND

Financial Performance

In 2025, Bachem Holding AG's revenue was 695.07 million, an increase of 14.84% compared to the previous year's 605.26 million. Earnings were 148.79 million, an increase of 23.74%.

Financial numbers in CHF